GenScript
Piscataway, NJ (US HQ); Nanjing, China (primary operations)
No confirmed program data — ClinicalTrials.gov verification pending
· Last scored 2026-09-07
64.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (19)
○ EMA GMP
○ MHRA GMP
Quick Facts: GenScript
- Signal Score
- 64.0/100 (as of 2026-09-07)
- Quality Compliance
- Assessment pending
- Headquarters
- Piscataway, NJ (US HQ); Nanjing, China (primary operations)
- Modalities
- CAR-T, Cell Therapy, Gene Editing
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About GenScript
BIOSECURE Act exposure via China operations.
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCAR-T, Cell Therapy, Gene Editing
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
65.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
63.0
Profile-based capacity assessment
Recent Press19 articles
Recent News 19 articles
GenScript Biotech rose more than 5% in early trading as Eli Lilly and Co announced a $7 billion acquisition of an in vivo CAR-T company. - 富途牛牛
GenScript Biotech rose more than 5% in early trading as Eli Lilly and Co announced a $7 billion acquisition of an in vivo CAR-T company. 富途牛牛
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - BioSpace
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era BioSpace
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - Dailyhunt
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era Dailyhunt
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - The Manila Times
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era The Manila Times
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - Thailand Business News
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era Thailand Business News
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - Bolsamania
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era Bolsamania
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - TNGlobal
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era TNGlobal
GenScript reports strong fiscal 2025 results from platform strategy - Vietnam Investment Review - VIR
GenScript reports strong fiscal 2025 results from platform strategy Vietnam Investment Review - VIR
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership - Indian Pharma Post
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership Indian Pharma Post
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth - Bolsamania
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth Bolsamania
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership - Indian Pharma Post
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership Indian Pharma Post
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership - Indian Pharma Post
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership Indian Pharma Post
GenScript opens its first European mRNA production site - Scientist Live
GenScript opens its first European mRNA production site Scientist Live
GenScript opens its first European mRNA production site - Scientist Live
GenScript opens its first European mRNA production site Scientist Live
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub - BioSpace
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub BioSpace
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub - The AI Journal
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub The AI Journal
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub - BeBeez International
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub BeBeez International
GenScript Opens First European mRNA Production Facility In Delft Strengthening Global Biotechnology Platform - BioPharma APAC
GenScript Opens First European mRNA Production Facility In Delft Strengthening Global Biotechnology Platform BioPharma APAC
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub - TNGlobal
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub TNGlobal
Frequently Asked Questions About GenScript
What is GenScript's CDMO Signal Score?
GenScript has a Signal Score of 64/100, based on quality, operations, financial stability, and capacity data.
Evaluating GenScript for a manufacturing program?
Use the free AI matchmaker to compare GenScript against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 90.9
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
RoslinCT
Edinburgh, UK · Hopkinton, MA
Signal Score: 80.3
CAR-T, Cell Therapy, iPSC, Gene Editing
CTMC
Houston, TX
Signal Score: 63.0
CAR-T, Cell Therapy, Gene Editing
Poseida Therapeutics (CDMO)
San Diego, CA
Signal Score: 58.7
CAR-T, Cell Therapy, Gene Editing
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 91.1
CAR-T, Cell Therapy